DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Dengler J, von Bubnoff N, Decker T, Peschel C, Duyster J.
Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib.
Leukemia 2005; 19: 1835-1838
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.